Springer Nature is making SARS-CoV-2 and COVID-19 research free.
View research |
View latest news |
Sign up for updates
From: Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker